Skip to main content

A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Subjects

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Transplant and Cellular Therapy

Awarded By

Astellas Pharma Global Development, Inc

Start Date

February 18, 2020

End Date

March 1, 2024
 

Administered By

Pediatrics, Transplant and Cellular Therapy

Awarded By

Astellas Pharma Global Development, Inc

Start Date

February 18, 2020

End Date

March 1, 2024